All data are based on the daily closing price as of December 26, 2025
k

KOBAYASHI Pharmaceutical

4967.TSE
34.23 USD
-0.01
-0.03%

Overview

Last close
34.23 usd
Market cap
2.54B usd
52 week high
40.54 usd
52 week low
33.09 usd
Target price
35.63 usd

Valuation

P/E
35.1517
Forward P/E
N/A
Price/Sales
2.4391
Price/Book Value
1.8771
Enterprise Value
2.18B usd
EV/Revenue
2.0882
EV/EBITDA
21.4023

Key financials

Revenue TTM
1.04B usd
Gross Profit TTM
535.20M usd
EBITDA TTM
184.40M usd
Earnings per Share
0.99 usd
Dividend
0.38 usd
Total assets
1.77B usd
Net debt
-301.45M usd

About

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese herbal medicine that promotes the breakdown and metabolism of fat; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air fresheners, lens cleaners, and oral hygiene products. It also manufactures and sells pharmaceuticals, fragrances, deodorants, cosmetics, health food, synthetic resin processed products, sanitary and paper products, hand warmers, aloe products, displays, models, mouthpieces, and kaiko; and sells daily necessities. In addition, the company engages in transportation, real estate management, advertising planning and production, and asset management activities. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
  • Symbol
    4967.TSE
  • Exchange
    TSE
  • Isin
    JP3301100008
  • Country
    Japan
  • Sector
    Consumer Defensive
  • Industry
    Household & Personal Products
  • CEO
    Mr. Kazumasa Kobayashi
  • Headquarter
    Osaka
  • Web site
    https://www.kobayashi.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top